Literature DB >> 11073819

Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas.

M Rothe1, Y Ko, P Albers, N Wernert.   

Abstract

Testicular germ cell tumors are important neoplasms and seminoma accounts for 40 to 50% of these tumors. Little is known concerning the molecular events underlying the development of these malignancies. In the present study we used a modified differential display approach to compare gene expression between seminoma and normal testicular parenchyma, both of which are mixed tissues. We first analyzed mRNA (cDNA) expression by differential display and then directly used differentially expressed cDNAs for the synthesis of radiolabeled riboprobes to attribute differential expression to specific cell types in tissue sections by in situ hybridization. Using this approach along with real-time quantitative reverse transcriptase-polymerase chain reaction analysis we found an overexpression of eukaryotic initiation factor 3 p110 mRNA (EIF3S8) in seminoma cells compared to normal germ cells of testicular tubules. The elF3-p110 subunit may promote seminoma development by generally increasing translation leading to enhanced cellular growth and division rates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073819      PMCID: PMC1885734          DOI: 10.1016/S0002-9440(10)64797-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

Review 1.  The role of eIF4 in cell proliferation.

Authors:  A Flynn; C G Proud
Journal:  Cancer Surv       Date:  1996

2.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.

Authors:  A Lazaris-Karatzas; K S Montine; N Sonenberg
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

3.  Staining of constitutive heterochromatin in mammalian chromosomes with a new fluorochrome.

Authors:  I Hilwig; A Gropp
Journal:  Exp Cell Res       Date:  1972-11       Impact factor: 3.905

Review 4.  Eukaryotic protein synthesis.

Authors:  K Moldave
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

5.  Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells.

Authors:  I B Rosenwald
Journal:  Cancer Lett       Date:  1996-04-19       Impact factor: 8.679

6.  Conservation and diversity of eukaryotic translation initiation factor eIF3.

Authors:  K Asano; T G Kinzy; W C Merrick; J W Hershey
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

7.  Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma.

Authors:  N Brass; D Heckel; U Sahin; M Pfreundschuh; G W Sybrecht; E Meese
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

8.  Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression.

Authors:  G Totzke; A Sachinidis; H Vetter; Y Ko
Journal:  Mol Cell Probes       Date:  1996-12       Impact factor: 2.365

9.  Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors.

Authors:  R M al-Jehani; S Povey; J D Delhanty; J M Parrington
Journal:  Genes Chromosomes Cancer       Date:  1995-08       Impact factor: 5.006

10.  Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo.

Authors:  B Vandenbunder; L Pardanaud; T Jaffredo; M A Mirabel; D Stehelin
Journal:  Development       Date:  1989-10       Impact factor: 6.868

View more
  20 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Authors:  Yi Gao; Jingfei Teng; Yi Hong; Fajun Qu; Jizhong Ren; Lin Li; Xiuwu Pan; Lu Chen; Lei Yin; Danfeng Xu; Xingang Cui
Journal:  Med Oncol       Date:  2015-06-03       Impact factor: 3.064

3.  eIF3 regulates migration, invasion and apoptosis in cadmium transformed 16HBE cells and is a novel biomarker of cadmium exposure in a rat model and in workers.

Authors:  Zhiheng Zhou; Qian Lu; Qinhai Huang; Chanjiao Zheng; Baoxin Chen; Yixiong Lei
Journal:  Toxicol Res (Camb)       Date:  2016-02-11       Impact factor: 3.524

4.  Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells.

Authors:  Jinmin Hao; Chaohui Liang; Baohua Jiao
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

Review 5.  eIF3: a factor for human health and disease.

Authors:  Andreia Gomes-Duarte; Rafaela Lacerda; Juliane Menezes; Luísa Romão
Journal:  RNA Biol       Date:  2017-11-13       Impact factor: 4.652

Review 6.  Translational control in cancer etiology.

Authors:  Davide Ruggero
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 7.  The cancerous translation apparatus.

Authors:  Craig R Stumpf; Davide Ruggero
Journal:  Curr Opin Genet Dev       Date:  2011-05-03       Impact factor: 5.578

8.  Loss of the eukaryotic initiation factor 3f in melanoma.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; Stanley P L Leong; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-10       Impact factor: 4.784

9.  Loss of the eukaryotic initiation factor 3f in pancreatic cancer.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; John T Cunningham; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

10.  Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.

Authors:  Hong Wang; Yuanbin Ru; Marta Sanchez-Carbayo; Xuejiao Wang; Jeffrey S Kieft; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2013-04-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.